Director/PDMR Shareholding

PROTEOME SCIENCES plc

("Proteome Sciences" or the "Company")

 

PRESS RELEASE

 

Issue of Equity, Directors' Dealings and Total Voting Rights

The Company has issued and allotted, subject to admission, 1,258,124 new ordinary shares of 1p each ("the Shares") following the exercise of options by Christopher Pearce, Chief Executive Officer, and James Malthouse, Finance Director.

The details of the options exercised are as follows:

Name                       Date of exercise  No. of options exercised  Exercise price 
Christopher Pearce         9 April 2008      450,000                   37p            
Christopher Pearce         9 April 2008      433,124                   45p            
James Malthouse            9 April 2008      375,000                   37p  
          
Following the exercise of the options, Christopher Pearce holds 6,538,075 ordinary shares, representing 4.93 per cent of the issued share capital.  James Malthouse holds 625,000 shares, representing 0.47 per cent of the issued share capital.
The Shares will rank equally with the existing ordinary shares of the Company. Application has been made for the Shares to be admitted to AIM. Trading is expected to commence on AIM on 16 April 2008 ("Admission").
For the purposes of the Financial Services Authority's Disclosure and Transparency Rules, following Admission the total number of ordinary shares of Proteome Sciences in issue will be 132,723,571 with each share holding one voting right.  The Company does not hold any ordinary shares in Treasury.  Therefore, the total number of ordinary shares with voting rights will be 132,723,571.

The above figure of 132,723,571 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.

 

                                     Ends                                      

 
Proteome Sciences plc


Christopher Pearce                       James Malthouse

Chief Executive Officer                  Finance Director

[e-mail]        [e-mail]

 
Tel: [phone]

 

Nominated Adviser

Landsbanki Securities (UK) Limited

Gareth Price / Thilo Hoffman             Tel:    [phone]